Combinations of peptides and peptides for use in immunotherapy for lung cancer, including non-small cell lung cancer (NSCLC) and other cancers

摘要

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to immunotherapy of cancer. The present invention also contemplates the use of a tumor-associated T cell epitope alone or in combination with other tumor-associated peptides capable of acting as an active pharmaceutical ingredient of a vaccine composition to stimulate an anti-tumor immune response or stimulate T cells ex vivo Lt; / RTI Peptides bound to molecules of the main histocompatibility complex (MHC). Such peptides may also be targets of antibodies, soluble T cell receptors and other binding molecules.